Lyu Yuan Y - OmicsDI

Show results for

Unknown (146)
Proteomics (15)
Metabolomics (1)

Organisms

Alphavirus (8)
Anemia (8)
Archaea (8)
Bacteria (8)
Betaherpesvirinae (8)
Borrelia (8)
Botrytis cinerea (8)
Chlorella vulgaris (8)
Clostridium perfringens (8)
Enterovirus A71 (8)
Eukaryota (8)
Hepatitis B virus (8)
Human alphaherpesvirus 1 (8)
Human betaherpesvirus 5 (8)
Influenza A virus (8)
Influenza C virus (8)
Japanese encephalitis virus group (8)
Listeria monocytogenes (8)
Mammarenavirus (8)
Miscanthus x giganteus (8)
Mycobacterium tuberculosis (8)
Orthoflavivirus (8)
Panicum virgatum (8)
Pseudomonas aeruginosa (8)
Rattus (8)
Homo sapiens (5)
Deinococcus radiodurans R1 = ATCC 13939 = DSM 20539 (1)
Escherichia coli (1)
Mus musculus (1)
Rattus norvegicus (1)

Repository

pride (8)
iProX (7)
MetaboLights (1)

Tissue

Epithelial cell (3)
Cell culture (2)
Permanent cell line cell (2)
Blood (1)
Blood cell (1)
Cerebrospinal fluid (1)
Colon (1)

Disease

Acute leukemia (2)
Influenza (2)
Disease free (1)
Nephrolithiasis (1)

Technology Type

Mass Spectrometry (8)
Affinity proteomics (2)
Bottom-up proteomics (2)
Data-dependent acquisition (2)
Olink affinity proteomics (2)
Shotgun proteomics (2)
Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2026 (4)
2025 (3)
2024 (3)
2022 (1)
2020 (1)
2023 (1)

CHEBI ID

CHEBI:175443 (1)
CHEBI:185275 (1)
CHEBI:174786 (1)
CHEBI:177995 (1)
CHEBI:89050 (1)
CHEBI:73803 (1)
CHEBI:171893 (1)
CHEBI:193361 (1)
CHEBI:175117 (1)
CHEBI:192311 (1)
CHEBI:7017 (1)
CHEBI:169239 (1)
CHEBI:192030 (1)
CHEBI:89410 (1)
CHEBI:175103 (1)
CHEBI:88430 (1)
CHEBI:191752 (1)
CHEBI:173507 (1)
CHEBI:177281 (1)
CHEBI:186973 (1)
CHEBI:175736 (1)
CHEBI:175374 (1)
CHEBI:175518 (1)
CHEBI:169238 (1)
CHEBI:6682 (1)
CHEBI:168616 (1)
CHEBI:80404 (1)
CHEBI:173845 (1)
CHEBI:174936 (1)
CHEBI:175740 (1)

Metabolite Name

(ÃÂ±)-2-(1-Methylpropyl)-4,6-dinitrophenol (1)
Ethyl dodecanoate (1)
2,3-Dihydroxybutanedioic acid (1)
Ethyl tetradecanoate (1)
Isohyodeoxycholic acid (1)
3-(3,4-Dihydroxy-5-methoxy)-2-propenoic acid (1)
Mesna (1)
Alpha-Hydroxyisobutyric acid (1)
Alpha-CEHC (1)
1,3,5-Trihydroxybenzene (1)
N-Formyl-L-aspartate (1)
Parabanic Acid (1)
8-iso-15-keto-PGE2 (1)
16-Methylheptadecanoic acid (1)
(R)-3-Hydroxybutyric acid (1)
Cholesterol sulfate (1)
Dihydrojasmonic acid (1)
Hydroxypyruvic acid (1)
Cohumulone (1)
Leukotriene B5 (1)
15-Keto-13,14-dihydroprostaglandin A2 (1)
Carnosic acid (1)
2-Oxovaleric acid (1)
3-Hydroxymethylglutaric acid (1)
4-Ethylbenzoic acid (1)
Gamma-CEHC (1)
Geranylgeranyl-PP (1)
Ethyl glucuronide (1)
15-Keto-prostaglandin E2 (1)
Pelargonic acid (1)

Modification

Not available (1)

Release Date

2025 (30)
2024 (30)
2022 (29)
2023 (25)
2021 (10)
2019 (10)
2020 (5)
2026 (4)
2015 (2)
2016 (1)

Lab affiliation

Department of Biochemistry and Structural Biology and Center for Innovative Drug Discovery School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States (2)
Sun Yat-sen University (2)
The First Affiliated Hospital of Fujian Medical University (2)
Tongji Hospital (1)
UT Health San Antonio (1)

Previous page
1 / 17
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 17
Next page

Sort by:

Relevance

Page size

Comparative metabolomic analysis of exudates of microcystin-producing and microcystin-free Microcystis aeruginosa strains

Cyanobacterial harmful algal blooms (cHABs) dominated by Microcystis aeruginosa threaten the ecological integrity and beneficial uses of lakes globally. In addition to producing hepatotoxic microcystins (MC), M. aeruginosa exudates (MaE) contain various compounds with demonstrat...

2023-01-16 | MTBLS6603 | MetaboLights

Development and crystal structures of a more potent second-generation dual degrader of BCL-2 and BCL-xL

Overexpression of BCL-xL and BCL-2 play key roles in tumorigenesis and cancer drug resistance. Advances in PROTAC technology facilitated recent development of the first BCL-xL/BCL-2 dual degrader, 753b, a VHL-based degrader with improved potency and reduced toxicity compared to previous small molec...

ORGANISM(S): Homo sapiens (Human)

2024-03-12 | PXD049976 | Pride